La. Dethloff et al., GASTRIC GLAND DEGENERATION INDUCED IN MONKEYS BY THE CCK-B GASTRIN RECEPTOR ANTAGONIST CI-988/, Toxicologic pathology, 25(5), 1997, pp. 441-448
Gastric effects of subchronic treatment with the cholecystokinin-B (CC
K-B)/gastrin receptor antagonist CI-988 were investigated in cynomolgu
s monkeys. In preliminary range-finding studies, CI-988 was given oral
ly to 1 monkey per sex for 14 days at doses of 50, 100, 200, and 500 m
g/kg/day. Subchronic studies of CI-988 were subsequently conducted usi
ng 5 monkeys per sex at doses of 0, 5, 25, and 75 mg/kg for 4 or 13 wk
. High-dose monkeys were dosed initially at 100 mg/kg, but the dose wa
s not well tolerated and was decreased to 75 mg/kg after 8 days of tre
atment. One male monkey at 75 mg/kg was euthanatized in estremis on da
y 23. In the range-finding study, minimal to moderate, multifocal to d
iffuse degeneration of gastric glands, primarily in the fundic region,
was observed at 100 mg/kg and above, with frank gastric mucosal atrop
hy occurring at 200 and 500 mg/kg. Minimal to mild gastric gland degen
eration was also observed in the subchronic study after 4 wk at 25 and
75 mg/kg, but histopathologic gastric changes were remarkably absent
after 13 wk. Mucosal height in the stomach fundus was decreased 19.8%
in 75-mg/kg males at week 4, and although gastric mucosa appeared hist
ologically normal after 13 wk, mucosal height remained 28.6% less than
that of controls. In females at 75 mg/kg, fundic mucosal height was d
ecreased 7% and 5% at weeks and 13, respectively, but decreases were n
ot statistically significant. Mean serum gastrin concentrations were i
ncreased 10-fold in males only after 4 wk at 75 mg/kg, but were compar
able to controls during week 13. CI-988-induced gastric gland degenera
tion is consistent with antagonism of gastrin's trophic activity towar
d gastric mucosa. Notwithstanding decrements in gastric mucosal height
, disappearance of mild histopathologic findings despite continued tre
atment with the ligand suggests some degree of adaptation to subchroni
c CCK-B/gastrin inhibition, although the mechanism of accomodation has
yet to be delineated.